TRLV Trulieve Cannabis Corp. Insider Trading

TRLV CEO Rivers sold 482,196 shares for $4.5M under pre-arranged 10b5-1 plan (3 sales, $9.36–$9.46/share)

Kim A. Rivers, Chairman and CEO, executed 3 separate sales totaling 482,196 shares for $4,525,972.74 across three trading days (June 17–22, 2026) at prices ranging from $9.36 to $9.46 per share, reducing his holdings from 3,175,920 shares to 2,693,724 shares (a -15.2% reduction). This sale was part of a pre-arranged 10b5-1 trading plan adopted on March 16, 2026, making it scheduled rather than discretionary. The timing of the sale occurs shortly after TRLV's recent listing (8 trading days prior), and while the company generated $286,754,000.00 in latest-quarter revenue, it reported negative full-year net income and a -0.4% annual revenue growth rate. The substantial size of the sale relative to the CEO's post-transaction holdings warrants attention to capital allocation decisions and whether the disposition reflects confidence in alternative uses of capital or market conditions.

Trulieve director Thronson buys 3,968 shares at $6.30 on 2024-11-20 for $24,998.40; holdings rise 68.7% to 9,740 shares

Director Thronson purchased 3,968 shares at $6.30 on 2024-11-20, increasing her stake by 68.7% relative to prior holdings. The timing of this discretionary purchase is noteworthy in context: Trulieve is unprofitable (full-year net income was negative, most recent quarter showed $-16.1M), though the company reported $302.1M in quarterly revenue with annual growth of 5.1%. The director's acquisition during a period of operational losses and negative earnings suggests an assessment independent of recent profitability. Investors should monitor whether this purchase pattern among directors broadens, and track the company's path to profitability alongside near-term stock performance.

Director Richard S. May bought 1,610 shares of TRUL at $6.05 on 2024-11-21, raising holdings to 570,096 shares.

Director Richard S. May purchased 1,610 shares at $6.05 for $9,740.50, a modest 0.3% net increase to an already substantial 570,096-share position. The company is currently unprofitable with full-year net income of $-16,111,000, though it reported quarterly revenue of $302,086,000 and demonstrated annual revenue growth of 5.1%. The small incremental buy—representing less than 2K shares—within an already large director holding suggests routine portfolio activity rather than a significant conviction signal. Given the company's near-recent listing status (13 trading days post-listing as of 2025-07-23) and lack of meaningful historical price data, the transaction's market timing and strategic intent cannot be assessed through standard valuation metrics.

CFO Getman Wes bought 9,500 shares of TRUL at $4.91 on 2024-12-11, raising holdings to 47,000 shares (+25.3%).

Getman Wes, Chief Financial Officer of Trulieve Cannabis Corp., purchased 9,500 shares at $4.91 on 2024-12-11, increasing his stake by 25.3% from 37,500 to 47,000 shares. The company reported negative net income of $-61.6M in its latest quarter and annual revenue growth of -8.9%, indicating sustained operational challenges. The purchase is noteworthy as it demonstrates direct capital commitment from a senior financial officer despite the unprofitable condition and revenue contraction, though the company's status as a recent listing (9 trading days) and the absence of meaningful 52-week context limit reliable assessment of market context for the transaction.

Director Healy Peter bought 8,130 shares of TRUL at $6.05; 11 other insiders bought within 14 days in cluster pattern.

Healy Peter's purchase of 8,130 shares at $6.05 on 2024-11-21 increased his holdings by 36.1% to 30,625 shares post-transaction. This buy occurs amid a broader cluster pattern: 11 other insiders also purchased shares within the past 14 days. The synchronized buying by multiple insiders during a period when the company reported a net loss of $61.6M in the latest quarter and full-year negative net income suggests insider confidence in the stock despite current unprofitability. The concurrent multi-insider buying activity warrants investor attention as a potential signal of management's conviction regarding near-term prospects or valuation opportunity.

Director Jane C. Morreau purchases 1,235 shares of TRUL at $6.06; 11 other insiders bought in past 14 days

Director Jane C. Morreau acquired 1,235 shares at $6.06, bringing her total holdings to 23,730 shares. This purchase is part of a cluster pattern: 11 other insiders also bought within the past 14 days, suggesting coordinated or simultaneous confidence-related activity across the insider group. The timing coincides with the company's recent listing (only 10 trading days prior), which may indicate insiders are establishing or building positions after the public market debut. However, Trulieve's fundamental backdrop is challenging—the company reported annual revenue growth of -8.9% and posted net income of -$61.6M on quarterly revenue of $284.3M, indicating sustained losses despite substantial revenues.

Director Richard S. May bought 1,160 shares of TRUL at $6.05; 11 other insiders also purchased in past 14 days amid unprofitable operations and -8.9% annual revenue decline.

Director Richard S. May purchased 1,160 shares at $6.05 on 2024-11-21, adding to his existing 551.0K share position. This transaction is part of a cluster pattern: 11 other insiders also bought within the past 14 days, signaling coordinated insider accumulation. The buying occurs against a backdrop of material operational headwinds—the company reported a net loss of $-61.6M in its latest quarter and is experiencing annual revenue decline of -8.9%, indicating the business is unprofitable and contracting. The cluster buy pattern in a recently listed stock suggests insiders are acquiring shares at current levels despite negative earnings and declining revenues. Investors should track whether this pattern represents conviction or relates to equity-based compensation vesting schedules.

Director Thronson bought 3,968 shares of TRUL at $6.30; 11 other insiders also bought within 14 days amid -8.9% revenue decline and -$61.6M net loss.

Susan Thronson, a Director, purchased 3,968 shares at $6.30 on 2024-11-20, increasing her holdings by 17.6% from 22,495 to 26,463 shares. This transaction occurs within a coordinated cluster pattern: 11 other insiders also purchased shares within the past 14 days, suggesting multi-level confidence in the company at current valuations. However, this buying activity contrasts sharply with Trulieve's operational backdrop: the company posted -$61.6M net income in the latest quarter while annual revenue declined 8.9% year-over-year, indicating persistent unprofitability and negative growth trends. The coincidence of significant insider accumulation amid deteriorating fundamentals warrants examination of whether insiders are viewing current valuations as attractive despite near-term headwinds, or whether non-public developments are driving the cluster activity.

CMO Collins Gina bought 1,250 shares of TRUL at $6.37; 11 other insiders also bought within 14 days amid unprofitable operations and -8.9% annual revenue decline

Collins Gina, Chief Marketing Officer, purchased 1,250 shares at $6.37 on 2024-11-12, bringing her holdings to 103,931 shares. This transaction occurred within a broader cluster pattern: 11 other insiders also bought within the past 14 days. The timing is notable given Trulieve's recent financial performance—the company posted a net loss of -$61.6M in the latest quarter and recorded annual revenue decline of -8.9%, while remaining unprofitable over the most recent full fiscal year. The coordinated buying activity by multiple insiders during a period of negative earnings and declining top-line growth presents a data point for investor consideration, though the company was recently listed (10 trading days) and 52-week metrics are not yet meaningful.

Director Thomas L. Millner bought 8,000 shares of TRUL at $6.12 on 2024-11-19 amid 11-insider cluster buy pattern.

Director Thomas L. Millner purchased 8,000 shares at $6.12, increasing his holdings from 22,495 shares to 30,495 shares (a +35.6% increase in stake). This transaction is noteworthy because it occurred as part of a cluster pattern: 11 other insiders also bought within the past 14 days, suggesting coordinated or spontaneous confidence at the current price level. Against the backdrop of challenging fundamentals—the company reported $-61.6M net income in the latest quarter and annual revenue declined -8.9% year-over-year—this cluster buying activity warrants close scrutiny. The concentration of insider purchasing activity in a compressed timeframe, especially by a director, indicates these insiders may perceive value despite near-term profitability headwinds.